...and CFO. He held the same position at Novelion Therapeutics Inc. (NASDAQ:NVLN). Gene therapy company Horama S.A....
...Staff Merck & Co. Inc. Ping An Healthcare and Technology Co. Ltd. Mirati Therapeutics Inc. Evox Therapeutics Ardelyx Inc. Akcea Therapeutics Inc. Horama S.A. Cellectis...

...as CMO, and McMurray was CSO and a co-founder of Outpost. Ophthalmology gene therapy company Horama S.A....
...firm Ceutec LLC, which he founded. Robin Sawka, BioCentury Staff Editas Medicine Inc. Immunocore Ltd. Spruce Biosciences Inc. Frazier Healthcare Partners Horama S.A. Nordic...

...company Pharming Group N.V. (Euronext:PHARM) said CFO Robin Wright will step down, effective May 20. Horama...
...Inc. Akcea Therapeutics Inc. Refuge Biotechnologies Inc. GammaDelta Therapeutics Ltd. Thermo Fisher Scientific Inc. Fujifilm Holdings Corp. NGM Biopharmaceuticals Inc. Pharming Group N.V. Horama S.A. Vectura...

...€19 million ($22.2 million) in the round from Kurma Partners, Fund+, Pontifax and Idinvest Partners. Horama’s...
...serotype 5 recombinant adeno-associated virus (rAAV) delivering the phosphodiesterase-6B (PDE-6B) gene. Horama S.A., Paris, France Jaime De Leon HORA-PDE6B Horama S.A. Phosphodiesterase-6B...

...Chintu Patel, who was co-CEO, co-chairman and co-founder of Amneal Pharmaceuticals Inc. (NYSE:AMRX). Ophthalmology company Horama S.A....

...series B round led by Kurma Partners, Fund+, Pontifax and Idinvest Partners. According to Kurma, Horama...
...advanced product is HORA-RPE65 to treat Leber’s congenital amaurosis (LCA) type 2. Horama S.A., Paris, France Shannon Lehnbeuter Horama S.A....

...series B round led by Kurma Partners, Fund+, Pontifax and Idinvest Partners. According to Kurma, Horama...
...of HORA-PDE6B “soon” to treat retinitis pigmentosa caused by mutations in the phosphodiesterase-6B (PDE6B) gene. Horama’s...

...company Horama S.A.S. has HORA-RPE65 in Phase I/II testing to treat Leber’s congenital amaurosis (LCA). Horama...
...Pharma S.A., Toulouse, France Genfit S.A. (Euronext:GNFT), Loos, France GenSight Biologics S.A. (Euronext:SIGHT), Paris, France Horama...
...Hansen, Associate Editor Cellectis S.A. DBV Technologies S.A. Eligo Bioscience S.A.S. Enterome Bioscience S.A. Enyo Pharma GamaMabs Pharma S.A. Genfit S.A. GenSight Biologics S.A. Horama...

...Phase I/II trials, but neither is in active development: rAAV2-CB-rhRPE65 from AGTC and HORA-RPE65 from Horama...
...Horama, however, decided to deprioritize its RPE65 product because Spark was so much further ahead. Horama...
...Mass. Celladon Corp. (NASDAQ:CLDN), San Diego, Calif. Dimension Therapeutics Inc., Cambridge, Mass. Genethon, Evry, France Horama...